Literature DB >> 30470303

The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer.

Olga Lancho1, Daniel Herranz2.   

Abstract

MYC is one of the most important oncogenes in cancer. Indeed, MYC is upregulated in 50-60% of all tumors. MYC overexpression can be achieved through a variety of mechanisms, including gene duplications, chromosomal translocations, or somatic mutations leading to increased MYC stability. However, recent studies have identified numerous tissue-specific noncoding enhancers of MYC that play major roles in cancer, highlighting long-range transcriptional regulation of MYC as a critical novel mechanism leading to MYC hyperactivation and as a potential target for new therapeutic strategies in the near future. Here we summarize the regions and mechanisms involved in the long-range transcriptional regulation of MYC, underscoring the relevance of MYC enhancers both in normal physiological development and in MYC-driven cancer initiation and progression.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MYC; SNP; cancer; enhancer; long-range transcriptional regulation

Mesh:

Substances:

Year:  2018        PMID: 30470303      PMCID: PMC6260942          DOI: 10.1016/j.trecan.2018.10.003

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  94 in total

1.  Long-range enhancers regulating Myc expression are required for normal facial morphogenesis.

Authors:  Veli Vural Uslu; Massimo Petretich; Sandra Ruf; Katja Langenfeld; Nuno A Fonseca; John C Marioni; François Spitz
Journal:  Nat Genet       Date:  2014-05-25       Impact factor: 38.330

2.  The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling.

Authors:  Sari Tuupanen; Mikko Turunen; Rainer Lehtonen; Outi Hallikas; Sakari Vanharanta; Teemu Kivioja; Mikael Björklund; Gonghong Wei; Jian Yan; Iina Niittymäki; Jukka-Pekka Mecklin; Heikki Järvinen; Ari Ristimäki; Mariachiara Di-Bernardo; Phil East; Luis Carvajal-Carmona; Richard S Houlston; Ian Tomlinson; Kimmo Palin; Esko Ukkonen; Auli Karhu; Jussi Taipale; Lauri A Aaltonen
Journal:  Nat Genet       Date:  2009-06-28       Impact factor: 38.330

3.  Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes.

Authors:  Jan J Molenaar; Jan Koster; Danny A Zwijnenburg; Peter van Sluis; Linda J Valentijn; Ida van der Ploeg; Mohamed Hamdi; Johan van Nes; Bart A Westerman; Jennemiek van Arkel; Marli E Ebus; Franciska Haneveld; Arjan Lakeman; Linda Schild; Piet Molenaar; Peter Stroeken; Max M van Noesel; Ingrid Ora; Evan E Santo; Huib N Caron; Ellen M Westerhout; Rogier Versteeg
Journal:  Nature       Date:  2012-02-22       Impact factor: 49.962

4.  Super-enhancers in the control of cell identity and disease.

Authors:  Denes Hnisz; Brian J Abraham; Tong Ihn Lee; Ashley Lau; Violaine Saint-André; Alla A Sigova; Heather A Hoke; Richard A Young
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

Review 5.  Cell fate control by pioneer transcription factors.

Authors:  Makiko Iwafuchi-Doi; Kenneth S Zaret
Journal:  Development       Date:  2016-06-01       Impact factor: 6.868

6.  Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.

Authors:  Franz X Schaub; Varsha Dhankani; Ashton C Berger; Mihir Trivedi; Anne B Richardson; Reid Shaw; Wei Zhao; Xiaoyang Zhang; Andrea Ventura; Yuexin Liu; Donald E Ayer; Peter J Hurlin; Andrew D Cherniack; Robert N Eisenman; Brady Bernard; Carla Grandori
Journal:  Cell Syst       Date:  2018-03-28       Impact factor: 10.304

7.  Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.

Authors:  Julius Gudmundsson; Patrick Sulem; Andrei Manolescu; Laufey T Amundadottir; Daniel Gudbjartsson; Agnar Helgason; Thorunn Rafnar; Jon T Bergthorsson; Bjarni A Agnarsson; Adam Baker; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Margret Jakobsdottir; Jianfeng Xu; Thorarinn Blondal; Jelena Kostic; Jielin Sun; Shyamali Ghosh; Simon N Stacey; Magali Mouy; Jona Saemundsdottir; Valgerdur M Backman; Kristleifur Kristjansson; Alejandro Tres; Alan W Partin; Marjo T Albers-Akkers; Javier Godino-Ivan Marcos; Patrick C Walsh; Dorine W Swinkels; Sebastian Navarrete; Sarah D Isaacs; Katja K Aben; Theresa Graif; John Cashy; Manuel Ruiz-Echarri; Kathleen E Wiley; Brian K Suarez; J Alfred Witjes; Mike Frigge; Carole Ober; Eirikur Jonsson; Gudmundur V Einarsson; Jose I Mayordomo; Lambertus A Kiemeney; William B Isaacs; William J Catalona; Rosa B Barkardottir; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2007-04-01       Impact factor: 38.330

Review 8.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

Review 9.  Looping back to leap forward: transcription enters a new era.

Authors:  Michael Levine; Claudia Cattoglio; Robert Tjian
Journal:  Cell       Date:  2014-03-27       Impact factor: 41.582

10.  IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation.

Authors:  Yavuz Oktay; Ege Ülgen; Özge Can; Cemaliye B Akyerli; Şirin Yüksel; Yiğit Erdemgil; I Melis Durası; Octavian Ioan Henegariu; E Paolo Nanni; Nathalie Selevsek; Jonas Grossmann; E Zeynep Erson-Omay; Hanwen Bai; Manu Gupta; William Lee; Şevin Turcan; Aysel Özpınar; Jason T Huse; M Aydın Sav; Adrienne Flanagan; Murat Günel; O Uğur Sezerman; M Cengiz Yakıcıer; M Necmettin Pamir; Koray Özduman
Journal:  Sci Rep       Date:  2016-06-10       Impact factor: 4.379

View more
  29 in total

Review 1.  3D Chromosomal Landscapes in Hematopoiesis and Immunity.

Authors:  Andreas Kloetgen; Palaniraja Thandapani; Aristotelis Tsirigos; Iannis Aifantis
Journal:  Trends Immunol       Date:  2019-08-15       Impact factor: 16.687

2.  Efficacy of combined CDK9/BET inhibition in preclinical models of MLL-rearranged acute leukemia.

Authors:  Hannah McCalmont; Ka Leung Li; Luke Jones; John Toubia; Sarah C Bray; Debora A Casolari; Chelsea Mayoh; Saumya E Samaraweera; Ian D Lewis; Rab K Prinjha; Nicholas Smithers; Shudong Wang; Richard B Lock; Richard J D'Andrea
Journal:  Blood Adv       Date:  2020-01-28

3.  Runx3 is required for oncogenic Myc upregulation in p53-deficient osteosarcoma.

Authors:  Shohei Otani; Yuki Date; Tomoya Ueno; Tomoko Ito; Shuhei Kajikawa; Keisuke Omori; Ichiro Taniuchi; Masahiro Umeda; Toshihisa Komori; Junya Toguchida; Kosei Ito
Journal:  Oncogene       Date:  2021-11-22       Impact factor: 9.867

4.  Notch signaling defects in NK cells in patients with cancer.

Authors:  Gulnur K Zakiryanova; Elena Kustova; Nataliya T Urazalieva; Emile T Baimukhametov; Valeriy A Makarov; Gulmariya M Turaly; Galina V Shurin; Zarema M Biyasheva; Narymzhan N Nakisbekov; Michael R Shurin
Journal:  Cancer Immunol Immunother       Date:  2020-10-21       Impact factor: 6.968

Review 5.  Obscure Involvement of MYC in Neurodegenerative Diseases and Neuronal Repair.

Authors:  Tatjana Marinkovic; Dragan Marinkovic
Journal:  Mol Neurobiol       Date:  2021-05-05       Impact factor: 5.590

6.  Exploration of Coding and Non-coding Variants in Cancer Using GenomePaint.

Authors:  Xin Zhou; Jian Wang; Jaimin Patel; Marc Valentine; Ying Shao; Scott Newman; Edgar Sioson; Liqing Tian; Yu Liu; Samuel W Brady; Diane Flasch; Xiaotu Ma; Yanling Liu; Robin Paul; Michael N Edmonson; Michael C Rusch; Chunliang Li; Suzanne J Baker; John Easton; Jinghui Zhang
Journal:  Cancer Cell       Date:  2021-01-11       Impact factor: 31.743

7.  A Tumor Suppressor Enhancer of PTEN in T-cell development and leukemia.

Authors:  Olga Lancho; Jui-Wan Loh; Amartya Singh; Shunsuke Kimura; Luca Tottone; Juliette Roels; Anna Kuchmiy; Steven Strubbe; Matthew A Lawlor; Victoria da Silva-Diz; Shirley Luo; Stéphanie Gachet; Carlos A García-Prieto; Rico Hagelaar; Manel Esteller; Jules P P Meijerink; Jean Soulier; Tom Taghon; Pieter Van Vlierberghe; Charles G Mullighan; Hossein Khiabanian; Pedro P Rocha; Daniel Herranz
Journal:  Blood Cancer Discov       Date:  2020-11-24

8.  DNA double-strand breaks induce H2Ax phosphorylation domains in a contact-dependent manner.

Authors:  Patrick L Collins; Caitlin Purman; Sofia I Porter; Vincent Nganga; Ankita Saini; Katharina E Hayer; Greer L Gurewitz; Barry P Sleckman; Jeffrey J Bednarski; Craig H Bassing; Eugene M Oltz
Journal:  Nat Commun       Date:  2020-06-22       Impact factor: 14.919

9.  Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia.

Authors:  Lindsey E Montefiori; Sonja Bendig; Zhaohui Gu; Xiaolong Chen; Petri Pölönen; Xiaotu Ma; Alex Murison; Andy Zeng; Laura Garcia-Prat; Kirsten Dickerson; Ilaria Iacobucci; Sherif Abdelhamed; Ryan Hiltenbrand; Paul E Mead; Cyrus M Mehr; Beisi Xu; Zhongshan Cheng; Ti-Cheng Chang; Tamara Westover; Jing Ma; Anna Stengel; Shunsuke Kimura; Chunxu Qu; Marcus B Valentine; Marissa Rashkovan; Selina Luger; Mark R Litzow; Jacob M Rowe; Monique L den Boer; Victoria Wang; Jun Yin; Steven M Kornblau; Stephen P Hunger; Mignon L Loh; Ching-Hon Pui; Wenjian Yang; Kristine R Crews; Kathryn G Roberts; Jun J Yang; Mary V Relling; William E Evans; Wendy Stock; Elisabeth M Paietta; Adolfo A Ferrando; Jinghui Zhang; Wolfgang Kern; Torsten Haferlach; Gang Wu; John E Dick; Jeffery M Klco; Claudia Haferlach; Charles G Mullighan
Journal:  Cancer Discov       Date:  2021-06-08       Impact factor: 39.397

Review 10.  Exploiting epigenetic dependencies in ovarian cancer therapy.

Authors:  Aisling Y Coughlan; Giuseppe Testa
Journal:  Int J Cancer       Date:  2021-08-06       Impact factor: 7.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.